Astal Laboratories Limited (ASTALLTD) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE307N01014
₹81.70+3.18 (+4.05%)
Key metrics
- Market Cap
- ₹361 Cr
- P/E Ratio
- 19.11
- EPS
- 4.31
- Book Value
- 79.06
- P/B Ratio
- 1.03
- ROE
- 2.43%
- ROCE
- 3.15%
- Debt / Equity
- 0.15
- Net Margin
- 5.2%
- Revenue Growth
- 142.87%
- Profit Growth
- -9.07%
- Dividend Yield
- —
- 52W High
- ₹103.20
- 52W Low
- ₹60.45
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Astal Laboratories Limited
Astal Laboratories Limited manufactures and sells pharmaceutical intermediates and bulk drugs in India. The company was formerly known as Macro International Limited and changed its name to Astal Laboratories Limited in April 2024. Astal Laboratories Limited was incorporated in 1993 and is headquartered in Jaipur, India. Astal Laboratories Limited operates as a subsidiary of Aceso Research Labs LLP.
- Headquarters
- Jaipur, India
- Promoter Holding
- 58.95%
The full Astal Laboratories Limited analysis
Create a free account to open the complete ASTALLTD deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.